Wellgistics Health

Wellgistics Health EBIT per Share

Delisted·Sep 22, 2026

The EBIT per Share of Wellgistics Health (WGRX) as of Oct 24, 2026 is -57.19 USD. In the previous year, EBIT per Share was -5.80 USD — a change of 886.20% (lower).

EBIT per Share

-57.19USD

YoY

886.20%

Last updated:

EBIT per Share of Wellgistics Health is 2025 -57.19 USD. EBIT per Share of Wellgistics Health was 2024 -5.80 USD. It decreases by 886.20% lower compared to the previous year.

The Wellgistics Health EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
-0.08 USD
Jan 1, 2023
-3.08 USD
Jan 1, 2024
-5.80 USD
Jan 1, 2025
-57.19 USD
The Wellgistics Health EBIT per Share history
YEAREBIT per ShareYoY
-57.19USD+886.20%
-5.80USD+88.39%
-3.08USD+3,921.88%
-0.08USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wellgistics Health Stock analysis

What does Wellgistics Health do? Wellgistics Health Inc generates revenue through its technology platform DelivMeds, which connects clinical services to pharmacy operations and enables an end-to-end mobile application for patients to digitize their prescription journey. The company focuses on specialty medications like Kyzatrex, Semaglutide, and Tirzepatide, offering home delivery services to patients through its community-based model. Its primary customers include pharmacies, providers, pharmaceutical manufacturers, and payors seeking solutions for specialty medication management. The company's subsidiaries Wood Sage, LLC and Wellgistics LLC operate under the holding company structure, while Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC provide indirect support for its pharmacy hub services. DelivMeds serves as the central technology platform that facilitates prescription digitization, price transparency, and concierge services, directly targeting patients and healthcare stakeholders. The company's product portfolio includes Kyzatrex, Semaglutide, and Tirzepatide, which are specialty medications delivered via home delivery. Pharmacies, providers, manufacturers, and payors purchase the company's services to improve patient outcomes and streamline medication management processes. The community-based model emphasizes patient autonomy and clinical integration through the DelivMeds platform. Wellgistics Health Inc's revenue streams are derived from its subsidiaries' operations, with Wood Sage, LLC and Wellgistics LLC managing direct service delivery, while Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC support pharmacy hub functions. The company monetizes its technology platform by enabling end-to-end mobile solutions for prescription management, which enhances patient experience and operational efficiency for its clients. Specialty medication products like Kyzatrex, Semaglutide, and Tirzepatide are key revenue drivers through home delivery services. Wellgistics Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wellgistics Health stock

EBIT per Share of Wellgistics Health is -57.19 USD in 2025.

EBIT per Share of Wellgistics Health changed from -5.80 USD to -57.19 USD, representing a 886.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Wellgistics Health since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Wellgistics Health

All Key Metrics — Wellgistics Health